Obesity-related complications such as non-alcoholic fatty liver disease (NAFLD) and type 2
diabetes (T2D) are well-established risk factors for the development of hepatocellular …

Kidney disease is one of the leading non-communicable diseases related to tremendous
health and economic burden globally. Diabetes, hypertension, obesity and cardiovascular …

The pathological conditions of nonalcoholic fatty liver disease and nonalcoholic
steatohepatitis (NASH) are the major risk factors for hepatocellular carcinoma (HCC) …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Its
incidence is progressively rising and it is possibly becoming a worldwide epidemic. NAFLD …

Backgrounds The extended duration of endoplasmic reticulum stress (ERS) can impact the
progression of hepatocellular carcinoma (HCC) and the efficacy of immunotherapies by …

Oropharyngeal squamous cell carcinoma (OPSCC), a subset of head and neck squamous
cell carcinoma (HNSCC), involves the palatine tonsils, soft palate, base of tongue, and …

Background Zinc finger and bric-a-brac/tramtrack/broad (ZBTB) domain-containing proteins
have been reported to be associated with many tumors' development. However, in tumor …

Nuclear receptors are transcription factors that function in normal physiology and play
important roles in diseases such as cancer, inflammation, and diabetes. Noninvasive …

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription
factors involved in various physiological and pathological processes within the skin. PPARs …

In this editorial we comment on the review by Zhou et al reviewing the landscape of
nanomedicine in the treatment of hepatocellular carcinoma (HCC). We focus on the …